Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bacteriostatic normal saline is a sterile, non-pyrogenic solution containing 0.9% sodium chloride and 0.9% (9 mg/mL) benzyl alcohol, which serves as a bacteriostatic preservative. While its primary regulatory indication is as a sterile vehicle for diluting or dissolving drugs for parenteral administration, it is frequently utilized off-label as a local anesthetic for minor procedures such as peripheral intravenous (IV) catheterization and intradermal skin wheals. The anesthetic effect is derived from the benzyl alcohol component, which acts as a local anesthetic by inhibiting nerve conduction. It is often preferred in clinical settings for patients with lidocaine hypersensitivity or to mitigate the stinging sensation typically associated with the administration of acidic local anesthetics like lidocaine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bacteriostatic normal saline (Allina Health).